Dr. Greenwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2085 Henry Tecklenburg Dr
Fl 2
Charleston, SC 29414Phone+1 843-577-6957Fax+1 843-577-6523
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2015 - 2018
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2015
- Medical University of South CarolinaClass of 2012
- Clemson UniversityBS, Chemical Engineering, 2001 - 2006
Certifications & Licensure
- SC State Medical License 2018 - 2025
- GA State Medical License 2015 - 2018
- MO State Medical License 2014 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Lymphoma Clinical Research Mentoring Program Scholar Lymphoma Research Foundation
- Chief Fellow Hematology/Medical Oncology, 2017-2018
- Arnold Endowed Scholarship 2008
Publications & Presentations
PubMed
- 4 citationsImpact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.Narendranath Epperla, Qiuhong Zhao, Reem Karmali, Pallawi Torka, Lauren Shea
Blood Advances. 2023-09-12 - 9 citationsImpact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Journal of Hematology & Oncology. 2023-05-08 - 88 citationsPI3K Inhibitors: Understanding Toxicity Mechanisms and Management.I. Brian Greenwell, Andrew Ip, Jonathon B. Cohen
Oncology. 2017-11-15
Abstracts/Posters
- Association of complex karyotype with inferior survival in mantle cell lymphoma is independent of specific cytogenetic abnormalitiesGreenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe D, Maly JJ, Blum KA, Grover NS, Mathews S, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, Flowe..., Society of Hematologic Oncology Annual Meeting, Houston TX, 1/7/2017
- Autologous stem cell transplantation is infrequently utilized but associated with improved overall survival in elderly patients with mantle cell lymphomaCohen JB, Greenwell IB, Lin Y, Behera M, Flowers CR, 14th International Conference on Malignant Lymphoma, Lugano, Switzerland, 1/1/2017
- Outcomes in Mantle Cell Lymphoma for Elderly Patients Undergoing Autologous Stem Cell Transplant in CR1Greenwell IB, Valla K, ASBMT Tandem Meetings, Orlando FL, 1/1/2017
- Join now to see all
Lectures
- Sickle Cell AnemiaAtlanta, GA - 1/1/2017
- Acute Leukemia: How to make it through the nightAtlanta, GA - 1/1/2017
- A comparison of consolidative autologous stem cell transplantation vs non-transplant consolidation in elderly patients with mantle cell lymphoma – PROP 1611-97Orlando, FL - 1/1/2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: